308 related articles for article (PubMed ID: 35953594)
1. Extrachromosomal DNA amplifications in cancer.
Yi E; Chamorro González R; Henssen AG; Verhaak RGW
Nat Rev Genet; 2022 Dec; 23(12):760-771. PubMed ID: 35953594
[TBL] [Abstract][Full Text] [Related]
2. The genomic and spatial mobility of extrachromosomal DNA and its implications for cancer therapy.
van Leen E; Brückner L; Henssen AG
Nat Genet; 2022 Feb; 54(2):107-114. PubMed ID: 35145302
[TBL] [Abstract][Full Text] [Related]
3. Extrachromosomal DNA in Cancer.
Bafna V; Mischel PS
Annu Rev Genomics Hum Genet; 2022 Aug; 23():29-52. PubMed ID: 35609926
[TBL] [Abstract][Full Text] [Related]
4. Gene regulation on extrachromosomal DNA.
Hung KL; Mischel PS; Chang HY
Nat Struct Mol Biol; 2022 Aug; 29(8):736-744. PubMed ID: 35948767
[TBL] [Abstract][Full Text] [Related]
5. Extrachromosomal DNA in cancer.
Yan X; Mischel P; Chang H
Nat Rev Cancer; 2024 Apr; 24(4):261-273. PubMed ID: 38409389
[TBL] [Abstract][Full Text] [Related]
6. Live-Cell Imaging Shows Uneven Segregation of Extrachromosomal DNA Elements and Transcriptionally Active Extrachromosomal DNA Hubs in Cancer.
Yi E; Gujar AD; Guthrie M; Kim H; Zhao D; Johnson KC; Amin SB; Costa ML; Yu Q; Das S; Jillette N; Clow PA; Cheng AW; Verhaak RGW
Cancer Discov; 2022 Feb; 12(2):468-483. PubMed ID: 34819316
[TBL] [Abstract][Full Text] [Related]
7. Extrachromosomal DNA: An Emerging Hallmark in Human Cancer.
Wu S; Bafna V; Chang HY; Mischel PS
Annu Rev Pathol; 2022 Jan; 17():367-386. PubMed ID: 34752712
[TBL] [Abstract][Full Text] [Related]
8. Pioneering insights of extrachromosomal DNA (ecDNA) generation, action and its implications for cancer therapy.
Li Z; Wang B; Liang H; Han L
Int J Biol Sci; 2022; 18(10):4006-4025. PubMed ID: 35844796
[TBL] [Abstract][Full Text] [Related]
9. ecDNA hubs drive cooperative intermolecular oncogene expression.
Hung KL; Yost KE; Xie L; Shi Q; Helmsauer K; Luebeck J; Schöpflin R; Lange JT; Chamorro González R; Weiser NE; Chen C; Valieva ME; Wong IT; Wu S; Dehkordi SR; Duffy CV; Kraft K; Tang J; Belk JA; Rose JC; Corces MR; Granja JM; Li R; Rajkumar U; Friedlein J; Bagchi A; Satpathy AT; Tjian R; Mundlos S; Bafna V; Henssen AG; Mischel PS; Liu Z; Chang HY
Nature; 2021 Dec; 600(7890):731-736. PubMed ID: 34819668
[TBL] [Abstract][Full Text] [Related]
10. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers.
Kim H; Nguyen NP; Turner K; Wu S; Gujar AD; Luebeck J; Liu J; Deshpande V; Rajkumar U; Namburi S; Amin SB; Yi E; Menghi F; Schulte JH; Henssen AG; Chang HY; Beck CR; Mischel PS; Bafna V; Verhaak RGW
Nat Genet; 2020 Sep; 52(9):891-897. PubMed ID: 32807987
[TBL] [Abstract][Full Text] [Related]
11. Breaking the vicious circle: Extrachromosomal circular DNA as an emerging player in tumour evolution.
Robert M; Crasta K
Semin Cell Dev Biol; 2022 Mar; 123():140-150. PubMed ID: 34857471
[TBL] [Abstract][Full Text] [Related]
12. Coordinated inheritance of extrachromosomal DNA species in human cancer cells.
Hung KL; Jones MG; Wong IT; Lange JT; Luebeck J; Scanu E; He BJ; Brückner L; Li R; González RC; Schmargon R; Dörr JR; Belk JA; Bafna V; Werner B; Huang W; Henssen AG; Mischel PS; Chang HY
bioRxiv; 2023 Jul; ():. PubMed ID: 37503111
[TBL] [Abstract][Full Text] [Related]
13. Extrachromosomal DNA (ecDNA) in cancer pathogenesis.
Wu S; Bafna V; Mischel PS
Curr Opin Genet Dev; 2021 Feb; 66():78-82. PubMed ID: 33477016
[TBL] [Abstract][Full Text] [Related]
14. Guilt by association: EcDNA as a mobile transactivator in cancer.
Zhu Y; Gong L; Wei CL
Trends Cancer; 2022 Sep; 8(9):747-758. PubMed ID: 35753910
[TBL] [Abstract][Full Text] [Related]
15. The evolutionary dynamics of extrachromosomal DNA in human cancers.
Lange JT; Rose JC; Chen CY; Pichugin Y; Xie L; Tang J; Hung KL; Yost KE; Shi Q; Erb ML; Rajkumar U; Wu S; Taschner-Mandl S; Bernkopf M; Swanton C; Liu Z; Huang W; Chang HY; Bafna V; Henssen AG; Werner B; Mischel PS
Nat Genet; 2022 Oct; 54(10):1527-1533. PubMed ID: 36123406
[TBL] [Abstract][Full Text] [Related]
16. Extrachromosomal circular DNA in colorectal cancer: biogenesis, function and potential as therapeutic target.
Chen Y; Qiu Q; She J; Yu J
Oncogene; 2023 Mar; 42(13):941-951. PubMed ID: 36859558
[TBL] [Abstract][Full Text] [Related]
17. Oncogene Convergence in Extrachromosomal DNA Hubs.
Weiser NE; Hung KL; Chang HY
Cancer Discov; 2022 May; 12(5):1195-1198. PubMed ID: 35398879
[TBL] [Abstract][Full Text] [Related]
18. Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.
Pongor LS; Schultz CW; Rinaldi L; Wangsa D; Redon CE; Takahashi N; Fialkoff G; Desai P; Zhang Y; Burkett S; Hermoni N; Vilk N; Gutin J; Gergely R; Zhao Y; Nichols S; Vilimas R; Sciuto L; Graham C; Caravaca JM; Turan S; Tsai-Wei S; Rajapakse VN; Kumar R; Upadhyay D; Kumar S; Kim YS; Roper N; Tran B; Hewitt SM; Kleiner DE; Aladjem MI; Friedman N; Hager GL; Pommier Y; Ried T; Thomas A
Cancer Discov; 2023 Apr; 13(4):928-949. PubMed ID: 36715552
[TBL] [Abstract][Full Text] [Related]
19. Insight on ecDNA-mediated tumorigenesis and drug resistance.
Huang Q; Zhang S; Wang G; Han J
Heliyon; 2024 Mar; 10(6):e27733. PubMed ID: 38545177
[TBL] [Abstract][Full Text] [Related]
20. Extrachromosomal DNA (ecDNA): an origin of tumor heterogeneity, genomic remodeling, and drug resistance.
Pecorino LT; Verhaak RGW; Henssen A; Mischel PS
Biochem Soc Trans; 2022 Dec; 50(6):1911-1920. PubMed ID: 36355400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
